Drug Manufacturers—General Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2166 |  MAZE Maze Therapeutics, Inc. - Common Stock | 25.88 USD | -1.41% | -4.43% | +6.68% | -42.53% | 1.44 B USD | ||
| 2169 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 29.85 USD | -3.27% | -10.44% | -31.14% | +13.97% | 1.43 B USD | ||
| 2823 |  CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 USD | +4.67% | -2.49% | -28.14% | +15.93% | 524.47 M USD | ||
| 3004 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 7.50 USD | -0.53% | -0.66% | -29.38% | -56.01% | 406.24 M USD | ||
| 3388 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 11.99 USD | -0.25% | -7.77% | -15.98% | -22.94% | 253.26 M USD | ||
| 3397 |  UPB Upstream Bio, Inc. - Common Stock | 4.55 USD | -1.30% | -6.76% | -22.35% | -77.02% | 249.21 M USD | ||
| 3424 |  QTTB Q32 Bio Inc. - Common Stock | 8.09 USD | +1.25% | -3.11% | -26.45% | +129.83% | 240.83 M USD | ||
| 3863 |  PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.00 USD | -4.31% | -2.44% | -2.91% | -95.56% | 99.69 M USD | ||
| 3886 |  OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 2.30 USD | -2.13% | -10.51% | -32.15% | -6.12% | 93.14 M USD | ||
| 3965 |  PTHS Pelthos Therapeutics Inc. Common Stock | 20.80 USD | -2.58% | +1.41% | -9.88% | -14.79% | 79.63 M USD | ||
| 3990 |  OSTX OS Therapies Incorporated Common Stock | 1.62 USD | +5.88% | -0.61% | -12.90% | +40.87% | 74.72 M USD | ||
| 4178 |  EXOZ eXoZymes Inc. - Common Stock | 5.33 USD | -3.79% | -7.47% | -13.75% | -45.05% | 49.47 M USD | ||
| 4183 |  VBIO Valion Bio, Inc. - Common stock | 2.21 USD | +0.91% | -13.33% | -7.14% | +84.17% | 49.04 M USD | ||
| 4193 |  DWTX Dogwood Therapeutics, Inc. - Common Stock | 1.41 USD | -1.40% | -7.84% | -27.32% | -53.00% | 47.93 M USD | ||
| 4312 |  IBO Impact BioMedical, Inc. Common Stock | 4.12 USD | -9.25% | -21.82% | +758.33% | +836.36% | 35.20 M USD | ||
| 4378 |  MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.70 USD | -1.41% | -4.11% | -11.39% | -48.15% | 29.42 M USD | ||
| 4415 |  SCLX Scilex Holding Company - Common Stock | 2.96 USD | -15.19% | -33.03% | -42.97% | -63.59% | 25.14 M USD | ||
| 4734 |  APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 USD | -22.09% | +32.44% | +136.09% | +314.50% | 8.19 M USD | ||
| 4786 |  MDCX Medicus Pharma Ltd. - Common Stock | 0.10 USD | -37.50% | -37.50% | -41.18% | -91.53% | 6.32 M USD | ||
| 4829 |  QCLS Q/C Technologies, Inc. - Common Stock | 0.64 USD | +1.59% | -17.95% | -63.22% | -83.42% | 5.24 M USD |
Nachrichten Drug Manufacturers—General Stocks
RBC Capital bestätigt „Outperform“ für Biogen und senkt das Kursziel auf 256 $
Nurix Therapeutics vor Quartalszahlen: Pipeline-Fortschritte im Fokus der Anleger
Myriad Genetics und SOPHiA GENETICS kooperieren mit AstraZeneca bei Prostatakrebs-Biomarker
SOPHiA GENETICS und Myriad Genetics arbeiten zusammen, um die neue technologie zur genomischen Instabilitätsbewertung speziell für Prostatakrebs voranzutreiben
Eli Lilly wird um über 21 % steigen? Hier sind 10 Top-Analystenprognosen für Donnerstag
Pipeline-Aussichten: Cantor Fitzgerald erhöht Kursziel für Pfizer-Aktie
Cantor Fitzgerald hebt Kursziel für Merck-Aktie wegen Ausblick auf 2027 an
Gainers Drug Manufacturers—General Stocks
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0497 | +34.32% |
 MANE Veradermics, Incorporated Common Stock | 126.68 | +13.94% |
OSTX OS Therapies Incorporated Common Stock | 1.62 | +5.88% |
 KAPA Kairos Pharma, Ltd. Common Stock | 0.93 | +5.68% |
CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 | +4.67% |
 GENB Generate Biomedicines, Inc. - Common Stock | 13.99 | +3.10% |
QCLS Q/C Technologies, Inc. - Common Stock | 0.64 | +1.59% |
 CGON CG Oncology, Inc. - Common stock | 63.26 | +1.41% |
Losers Drug Manufacturers—General Stocks
MDCX Medicus Pharma Ltd. - Common Stock | 0.10 | -37.50% |
APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 | -22.09% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0319 | -16.05% |
SCLX Scilex Holding Company - Common Stock | 2.96 | -15.19% |
IBO Impact BioMedical, Inc. Common Stock | 4.12 | -9.25% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 0.47 | -6.00% |
 DCOY Decoy Therapeutics Inc. - Common Stock | 1.52 | -5.59% |
 VIVS VivoSim Labs, Inc. - Common Stock | 0.18 | -5.26% |